Nucleus Software Exports (531209) Q3 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 25/26 earnings summary
11 Feb, 2026Executive summary
Achieved steady performance in Q3 FY2025, with continued progress on long-term strategy and order bookings.
Welcomed a new Chief Business Officer to strengthen leadership and business development.
Audited standalone and unaudited consolidated financial results for the quarter and nine months ended December 31, 2025, were approved by the Board and reviewed by the Audit Committee.
Statutory auditors expressed an unmodified opinion on standalone results and a clean review conclusion on consolidated results.
Financial highlights
Consolidated revenue for the quarter was INR 200.03 crore (₹22,003 lakh), up from INR 205.7 crore (₹20,570 lakh) year-over-year; nine-month revenue was ₹65,126 lakh, up from ₹60,329 lakh year-over-year.
Net profit for the quarter was INR 20.7 crore (₹2,070 lakh), down from INR 24.97 crore (₹3,497 lakh) year-over-year; nine-month profit was ₹8,219 lakh, down from ₹9,823 lakh year-over-year.
Product revenue reached INR 185.58 crore, up both sequentially and year-over-year.
EBITDA stood at INR 32.72 crore, up from INR 23.08 crore sequentially but slightly down from INR 33.02 crore year-over-year.
EPS for the quarter was INR 7.86 (₹7.86, not annualised), compared to INR 13.28 (₹13.28) year-over-year.
Outlook and guidance
No specific revenue or earnings guidance provided.
Management expects cost of delivery to rise slightly due to new labor codes, but aims to contain costs through efficiency and AI adoption.
The company continues to monitor the impact of new Labour Codes and will evaluate further effects on employee benefit liabilities as developments occur.
Significant deal pipeline expected to convert in coming quarters, with focus on both new client acquisition and migration of existing clients.
Latest events from Nucleus Software Exports
- Revenue and profit rose year-over-year, with robust order book, dividend, buyback, and product go-lives.531209
Q1 25/263 Feb 2026 - Revenue and profit fell, India led segments, and a final dividend of INR 12.50 was paid.531209
Q1 24/252 Feb 2026 - Sequential profit and revenue growth, strong cash, but longer sales cycles slow order conversion.531209
Q2 24/2514 Jan 2026 - Quarterly revenue and profit rose, with strong order book and shareholder returns.531209
Q3 24/259 Jan 2026 - Revenue up, profit down year-over-year, dividend and buyback mark capital return.531209
Q4 24/2526 Nov 2025 - Revenue and profit fell sequentially, but capital returns and India segment remained strong.531209
Q2 25/2610 Nov 2025